RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pan, Yi ^a   Li, GuangMing ^a   Zhong, HengGao ^a,b   Chen, MeiJuan ^c   Chen, TingTing ^a   Gao, LiLi ^a   Wu, HuiWen ^a   Guo, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; DDX58 PROTEIN, MOUSE; PROTEIN TYROSINE KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; STAT3 PROTEIN;

ANIMAL; BINDING COMPETITION; CELL PROLIFERATION; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DEAD BOX PROTEIN 58; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INSULIN-SECRETING CELLS; MALE; MICE, INBRED ICR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR;

EID: 84976559060     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28914     Document Type: Article

References (52)

1. Golson, M. L., Misfeldt, A. A., Kopsombut, U. G., Petersen, C. P. & Gannon, M. High fat diet regulation of beta-Cell proliferation and beta-Cell mass. Open Endocrinol J. 4, (2010).
2. Marchetti, P. et al. Goals of treatment for type 2 diabetes: Beta-cell preservation for glycemic control. Diabetes Care 32 Suppl 2, S178-S183 (2009).
3. Yin, J., Peng, Y., Wu, J., Wang, Y. & Yao, L. Toll-like receptor 2/4 links to free fatty acid-induced inflammation and beta-cell dysfunction. J Leukoc Biol 95, 47-52 (2014).
4. Li, X. Y. et al. RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness. Mol Cell. 53, 407-419 (2014).
5. Cai, T. et al. Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2. Am J Cancer Res 5, 1610-1620 (2015).
6. Sato, Y. et al. Palmitate induces reactive oxygen species production and beta-cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling. J Diabetes Investig. 5, 19-26 (2014).
7. Alshaker, H. et al. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res. 16, 426 (2014).
8. Lin, C. C. et al. Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts. J Biomed Sci. 22, 53 (2015).
9. Boekhoudt, G. H., McGrath, A. G., Swisher, J. F. & Feldman, G. M. Immune complexes suppress IFN-gamma-induced responses in monocytes by activating discrete members of the SRC kinase family. J Immunol. 194, 983-989 (2015).
10. Chen, Q. et al. The importance of Src signaling in sarcoma. Oncol Lett. 10, 17-22 (2015).
11. Chen, B., Xu, X., Luo, J., Wang, H. & Zhou, S. Rapamycin enhances the Anti-Cancer effect of dasatinib by suppressing Src/PI3K/ mTOR pathway in NSCLC cells. Plos One. 10, e129663 (2015).
12. Zhang, T. et al. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs. J Mol Histol. 46, 485-497 (2015).
13. Chu, I. et al. P27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell. 128, 281-294 (2007).
14. Kuo, C. T., Chang, C. & Lee, W. S. Folic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRalpha/c-SRC/ERK1/2/NFkappaB/TP53 pathway: In vitro and in vivo studies. Sci Rep. 5, 11187 (2015).
15. Cen, B., Li, H. & Weinstein, I. B. Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src. J BIOL CHEM. 284, 5265-5276 (2009).
16. Chan, C. H., Lee, S. W., Wang, J. & Lin, H. K. Regulation of Skp2 expression and activity and its role in cancer progression. ScientificWorldJournal. 10, 1001-1015 (2010).
17. Chen, J. Y., Wang, M. C. & Hung, W. C. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. J Cell Physiol. 226, 407-413 (2011).
18. Wei, Z. et al. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal. 25, 931-938 (2013).
19. Tanti, J. F., Ceppo, F., Jager, J. & Berthou, F. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 3, 181 (2012).
20. Han, D. et al. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic beta-cell failure in type 2 diabetes. Genes Cells. 18, 302-314 (2013).
21. Kim, Y. J. et al. Decreased pattern-recognition receptor-mediated cytokine mRNA expression in obese children with otitis media with effusion. Clin Exp Otorhinolaryngol. 7, 7-12 (2014).
22. Sarmiento, L. et al. Expression of innate immunity genes and damage of primary human pancreatic islets by epidemic strains of Echovirus: Implication for post-virus islet autoimmunity. Plos One. 8, e77850 (2013).
23. Wang, Y. et al. Elevated toll-like receptor 3 inhibits pancreatic beta-cell proliferation through G1 phase cell cycle arrest. Mol Cell Endocrinol. 377, 112-122 (2013).
24. Han, X., Sun, Y., Scott, S. & Bleich, D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes. 50, 1047-1055 (2001).
25. Kang, H. C. & Bae, Y. H. Transfection of rat pancreatic islet tissue by polymeric gene vectors. Diabetes Technol Ther. 11, 443-449 (2009).
26. Gao, L. et al. Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NFkappaB/ c-Myc Pathway in Pancreatic beta cells. Mol Med. 21, 154-166 (2015).
27. Gu, L. et al. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi. J Neuroinflammation. 10, 109 (2013).
28. Chen, S. S. et al. Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic beta-cells. Biochem Biophys Res Commun. 443, 814-820 (2014).
29. Meng, Z. X. et al. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia. 52, 125-135 (2009).
30. Feng, X. et al. Functional characterizations of IPS-1 in CIK cells: Potential roles in regulating IFN-I response dependent on IRF7 but not IRF3. Dev Comp Immunol. 53, 23-32 (2015).
31. Min, H. Y. et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 14, 113 (2015).
32. Huang, H., Zhao, W. & Yang, D. Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells. Biochem Biophys Res Commun. 418, 186-190 (2012).
33. Schreiner, S. J., Schiavone, A. P. & Smithgall, T. E. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J Biol Chem. 277, 45680-45687 (2002).
34. Kominato, R. et al. Src activation generates reactive oxygen species and impairs metabolism-secretion coupling in diabetic Goto-Kakizaki and ouabain-treated rat pancreatic islets. Diabetologia. 51, 1226-1235 (2008).
35. Matsumoto, T., Kobayashi, T., Ishida, K., Taguchi, K. & Kamata, K. Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes. Br J Pharmacol. 160, 1092-1104 (2010).
36. Gupte, R. S. et al. Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic Biol Med. 47, 219-228 (2009).
37. Je, D. W., O, Y. M., Ji, Y. G., Cho, Y. & Lee, D. H. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion. Pancreas. 43, 768-776 (2014).
38. Song, Y. et al. Activated PKR inhibits pancreatic beta-cell proliferation through sumoylation-dependent stabilization of P53. Mol Immunol. 68, 341-349 (2015).
39. Matikainen, S. et al. Tumor necrosis factor alpha enhances influenza a virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol. 80, 3515-3522 (2006).
40. Malin, S. K., Kirwan, J. P., Sia, C. L. & Gonzalez, F. Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic beta-cell dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metab. 99, 322-329 (2014).
41. Tal, M. C. et al. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 106, 2770-2775 (2009).
42. Aida, K. et al. RIG-I-and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes. 60, 884-889 (2011).
43. Prasad, S. B. et al. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Cell Oncol (Dordr). 38, 215-225 (2015).
44. Su, L., Han, D., Wu, J. & Huo, X. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. Tumour Biol (2015).
45. Hafez, M. M. et al. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients. Asian Pac J Cancer Prev. 16, 5807-5815 (2015).
46. Hnit, S. S. et al. P27(Kip1) signaling: Transcriptional and post-translational regulation. Int J Biochem Cell Biol. 68, 9-14 (2015).
47. Liu, Y. et al. A relationship between p27(kip1) and Skp2 after adult brain injury: Implications for glial proliferation. J Neurotrauma. 27, 361-371 (2010).
48. Zhong, L. et al. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. J Clin Invest 117, 2869-2876 (2007).
49. Lee, J. J. et al. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells. Cell Death Dis. 5, e1537 (2014).
50. Koo, K. H. et al. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Cell Death Dis. 4, e693 (2013).
51. Kou, Z. Z. et al. Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes. Pain Physician. 16, E71-E83 (2013).
52. Pan, Q. et al. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways. J Exp Clin Cancer Res. 34, 77 (2015).